Skip to content
Search

Latest Stories

Top 3 essential medical screenings for women in their 30s

Proactive health choices for a healthy future

Essential medical screenings

Preventive care through routine check-ups

iStock

As women enter their 30s, life becomes increasingly demanding, with careers, relationships, and personal responsibilities taking centre stage. However, amidst all these commitments, maintaining one’s health is of paramount importance. Regular medical screenings play a critical role in the early detection of potential health concerns, allowing for timely intervention and treatment. For women in their 30s, preventive care through routine check-ups can help maintain overall well-being and ensure a healthy future. Here are the top three medical screenings every woman in her 30s should prioritise.

1. Cervical screening

Cervical screening, commonly referred to as the smear test, is a crucial preventive measure in the fight against cervical cancer. In the UK, women aged 25 to 64 are invited to have a cervical screening every three years, and it is especially important for those in their 30s. The smear test detects abnormal changes in the cells of the cervix, which can potentially develop into cervical cancer if left untreated.


Cervical cancer is often caused by persistent infection with high-risk strains of the human papillomavirus (HPV), particularly HPV types 16 and 18. These infections are quite common, but in some cases, they can lead to abnormal cell growth, making early detection vital. The smear test itself is a quick and simple procedure that can be done at your GP’s office. It may cause some mild discomfort, but it is not painful.

Missing your scheduled cervical screening could increase the risk of developing cancer, even if you feel healthy. This screening is one of the most effective ways to catch pre-cancerous cells before they have the chance to develop into something more serious. The NHS sends reminders for cervical screening, so you must keep your contact details updated with your GP to ensure you receive these invitations.

By attending regular cervical screenings, women in their 30s can significantly reduce the risk of cervical cancer. Early detection allows for early treatment and, in most cases, prevents the development of cancer altogether.

2. Breast health screening

Although routine mammograms are not typically offered to women until the age of 50 in the UK, breast health awareness remains critically important in your 30s. Breast cancer can occur at any age, and early detection is key to successful treatment.

Regular self-examinations are the most accessible form of breast health screening for women in their 30s. By performing a breast self-exam once a month, women can become familiar with the normal look and feel of their breasts, making it easier to detect any changes, such as lumps, skin dimpling, nipple discharge, or changes in size or shape. The best time to perform a self-exam is a few days after your period when breasts are less tender.

While mammograms are generally offered to women over 50, those with a family history of breast or ovarian cancer should discuss with their GP whether early or more frequent mammograms are necessary. Women with a genetic predisposition to breast cancer may also be eligible for earlier screenings.

Taking breast health seriously in your 30s is crucial because catching any changes early can significantly increase the chances of effective treatment. If you notice anything unusual during a self-exam, it’s important to consult your GP right away for further evaluation.

3. Sexually transmitted infection screening

Sexual health is a vital component of overall well-being, and regular screening for sexually transmitted infections (STIs) is essential for all sexually active women, regardless of age. Many STIs, such as chlamydia, gonorrhoea, HIV, and syphilis, can have serious long-term consequences if left untreated, including infertility and other health complications.

Chlamydia is particularly concerning in the UK, where it is the most common STI, especially among young adults. Unfortunately, many STIs, including chlamydia, often present with no symptoms, making regular screening even more important. Women in their 30s who are sexually active, especially those with new or multiple partners, should consider regular STI testing as part of their routine health care.

Testing for STIs is quick and easy, with many tests involving a simple urine sample, blood test, or swab. The NHS offers STI testing at GPs and sexual health clinics, and home testing kits are also available for convenience. Regular STI screenings can prevent the spread of infections to others and allow for timely treatment to avoid serious health complications.

Even women in long-term, monogamous relationships may consider STI screening if there are concerns about previous infections or potential exposure. HIV testing is also crucial, as early detection allows for effective treatment that improves quality of life and reduces the risk of transmission to others.

Prioritising health in your 30s

In your 30s, maintaining a proactive approach to healthcare is essential for long-term well-being. By prioritising cervical screenings, staying vigilant about breast health, and undergoing regular STI testing, women can protect their health and prevent serious conditions from developing. Early detection is key, and many of these tests are quick, non-invasive, and readily available through the NHS or your GP. Making time for these essential screenings now will help safeguard your future health, allowing you to live a healthier, more fulfilling life.

Taking control of your health begins with being informed and taking preventive action. Be sure to schedule your next medical screening and encourage the women around you to do the same – your health is worth it.

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Serena Williams

Williams explained that her weight challenges began after the birth of her first daughter

Getty Images

Serena Williams says GLP-1 made her feel light physically and mentally after 31lb loss

Highlights:

  • Serena Williams reveals she has lost more than 31lbs using a GLP-1 medication
  • The tennis legend says the treatment enhanced her existing healthy lifestyle
  • She stresses that weight loss should not change self-image or self-confidence

Serena Williams has revealed she has lost more than 31lbs after turning to a weight-loss medication, saying the treatment has transformed both her body and her mindset.

The 23-time Grand Slam champion, 43, told PEOPLE that using a GLP-1 medication — a type of injection that works by regulating appetite — has helped enhance the healthy lifestyle she already maintained through diet and exercise.

Keep ReadingShow less
Monica Seles

Seles first began noticing symptoms around five years ago

Getty Images

Tennis champion Monica Seles reveals living with myasthenia gravis

Highlights:

  • Nine-time Grand Slam winner Monica Seles diagnosed with myasthenia gravis three years ago
  • The 51-year-old revealed her condition ahead of this month’s US Open to raise awareness
  • Disease causes muscle weakness and has no known cure

Former world number one Monica Seles has revealed she was diagnosed with myasthenia gravis, a rare neuromuscular autoimmune disease, three years ago. The 51-year-old, who won nine Grand Slam singles titles, went public ahead of the US Open to raise awareness of the condition, which causes muscle weakness and can affect multiple parts of the body.

Symptoms and diagnosis

Seles first began noticing symptoms around five years ago when she experienced double vision and struggled with coordination. “I would be playing [tennis] with some kids or family members, and I would miss a ball. I was like, ‘Yeah, I see two balls,’” she told the Associated Press. These symptoms eventually led to her diagnosis, which took time for her to come to terms with.

Keep ReadingShow less
faulty knee implant NHS recall

Hundreds of patients required corrective surgery

iStock

Faulty knee implant recalled after being used in over 10,000 NHS surgeries

Highlights:

  • NexGen knee implant linked to high failure rates was used in over 10,000 UK operations.
  • Concerns flagged as early as 2014; withdrawn from UK market in 2022.
  • Hundreds of patients required corrective surgery, with costs running into millions.
  • Manufacturer Zimmer Biomet says patient safety is its “top priority” but will not cover revision costs up front.

Implant used despite early warnings

A knee replacement implant used in thousands of NHS operations was known to have a concerning failure rate eight years before it was withdrawn, a BBC File on 4 Investigates report has found.

The NexGen implant, made by US manufacturer Zimmer Biomet, was fitted in more than 10,000 patients between 2012 and 2022. Concerns were first raised by the National Joint Registry (NJR) in 2014, though insufficient data at the time made it difficult to draw firm conclusions.

Keep ReadingShow less